Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
QuintilesIMS
Queensland Health
Baxter
Colorcon
Healthtrust
AstraZeneca
Julphar

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Rigosertib

« Back to Dashboard

US Patents for Rigosertib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Rigosertib ➤ Sign Up Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders Temple University - Of the Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Sign Up
Rigosertib ➤ Sign Up Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones Onconova Therapeutics, Inc. (Newtown, PA) ➤ Sign Up
Rigosertib ➤ Sign Up Composition and methods for the treatment of proliferative diseases Temple University - Of The Commonwealth System of Higher Education (Philadelphia, PA) Mount Sinai School of Medicine (New York, NY) ➤ Sign Up
Rigosertib ➤ Sign Up Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Sign Up
Rigosertib ➤ Sign Up Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Sign Up
Rigosertib ➤ Sign Up Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones Onconova Therapeutics, Inc (Newtown, PA) ➤ Sign Up
Rigosertib ➤ Sign Up Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia Temple University--Of the Commonwealth System of Higher Education (Philadelphia, PA) Icahn School of Medicine at Mount Sinai (New York, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Rigosertib

Drugname Country Document Number Estimated Expiration Related US Patent
Rigosertib Austria 525067 2022-02-28 ➤ Sign Up
Rigosertib Australia 2003213660 2022-02-28 ➤ Sign Up
Rigosertib Canada 2477232 2022-02-28 ➤ Sign Up
Rigosertib Eurasian Patent Organization 008736 2022-02-28 ➤ Sign Up
Rigosertib Eurasian Patent Organization 200401124 2022-02-28 ➤ Sign Up
Rigosertib European Patent Office 1487428 2022-02-28 ➤ Sign Up
Rigosertib Spain 2373945 2022-02-28 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
McKinsey
Julphar
Mallinckrodt
Merck
Moodys
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.